Acephalgic migraine, also called a silent migraine, is a form of migraine in which a person experiences the transient neurological disturbances known as an aura but does not develop the headache that usually follows. The term acephalgic comes from Latin roots meaning "without head pain." Although many migraine types begin in young adulthood, acephalgic attacks often first appear in middle age and may become more noticeable with advancing years. Unlike the more common migraine with pain, acephalgic migraine is reported relatively frequently in men as well as women.

Symptoms and typical features

The defining characteristic is an aura occurring in isolation from headache. Auras usually develop gradually over several minutes and may include one or more of the following:

  • Visual disturbances: flashing lights, zigzag lines, shimmering or fortification spectra, blind spots (scotomas), or flickering patterns.
  • Sensory symptoms: pins-and-needles, numbness, or a tingling sensation on one side of the body or face.
  • Language or speech problems: difficulty finding words (transient aphasia) or slowed speech.
  • Dizziness, imbalance, or transient weakness in rare cases.

Individual attacks are usually short-lived, often lasting minutes to an hour, but patterns vary; some people describe prolonged or recurrent aura episodes without headache.

Causes, triggers and epidemiology

Acephalgic migraine shares many presumed mechanisms with other migraine types, including transient changes in brain excitability and cortical spreading depression that underlie aura symptoms. Common triggers reported by people with migraine—such as stress, sleep changes, certain foods, hormonal fluctuations, or sensory overstimulation—may also precipitate acephalgic episodes. The condition is not fully understood, and its onset later in life means clinicians must carefully evaluate new symptoms to exclude other causes.

Diagnosis and differential considerations

Diagnosis relies on a characteristic history of transient neurologic symptoms consistent with migraine aura and the absence of a subsequent headache. Because the symptoms can mimic other serious conditions, clinicians commonly perform investigations to rule out alternative causes. Important differentials include:

  • Transient ischemic attack (TIA) or stroke — particularly when symptoms begin suddenly and in older adults or those with vascular risk factors.
  • Occipital lobe seizures or focal epilepsy, which can produce brief visual phenomena.
  • Ocular problems such as retinal detachment or vascular events affecting the eye.

Assessment strategies often include a detailed neurological examination, brain imaging (usually MRI), and, in select cases, electroencephalography (EEG) or vascular studies.

Treatment, management and prognosis

Treatment focuses on reassurance, identifying and avoiding triggers, and reducing attack frequency when episodes are frequent or disabling. Because there is no pain phase, many standard acute analgesic strategies are unnecessary; however, some people benefit from preventive medications used in migraine (for example, beta-blockers, anticonvulsants, or calcium channel blockers) when auras are recurrent. If the presentation is new or atypical, immediate evaluation is warranted to exclude stroke or other urgent causes. Overall prognosis is variable: some individuals have isolated episodes, while others experience recurring silent auras over years. Long-term follow-up helps tailor therapy and monitor for any evolution into other migraine types or emergence of vascular risk factors.

For authoritative diagnostic criteria and guidance on management, clinicians refer to headache classification systems and neurology resources; patients experiencing new-onset or changing aura symptoms should seek timely medical review.